ACTHAR GEL

Peak

repository corticotropin

NDAINJECTIONINJECTABLE
Approved
Apr 1952
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

unknown. Acthar Gel and endogenous ACTH stimulate the adrenal cortex to secrete cortisol, corticosterone, aldosterone, and a number of weakly androgenic substances. Prolonged administration of large doses of Acthar Gel induces hyperplasia and hypertrophy of the adrenal cortex and continuous high…

Pharmacologic Class:

Adrenocorticotropic Hormone

Indications (4)

exacerbations of multiple sclerosis in adultsacute exacerbations of multiple sclerosis in adultsmultiple sclerosisRheumatoid arthritis

Loss of Exclusivity

LOE Date
Jul 18, 2041
187 months away
Patent Expiry
Jul 18, 2041

Patent Records (1)

Patent #ExpiryTypeUse Code
11752199
Jul 18, 2041
U-3688
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers